Considering the significant health benefits and reduced medical costs from treating obesity, the National Consumers League urges Rhode Islands General Assembly to maintain GLP-1 obesity treatment coverage for Medicaid patients
GLP-1s are prescribed to adults with a BMI over 30, or adults with a BMI over 27 who also have obesity-related conditions, such as prediabetes, diabetes, high blood pressure, high cholesterol, sleep apnea, and fatty liver disease
PlexusDx supports personalized evaluation by combining biomarker context, genetic predisposition screening, and compounded medication options with healthcare provider guidance
One from histidines imidazole ring
Have a history of severe asthma with sulfite sensitivity